Women

Women are more likely than men to experience iron deficiency (ID) and iron deficiency anemia (IDA). ACCRUFeR® (ferric maltol) is clinically proven to deliver rapid and effective results for adults with ID/IDA.

Black woman smiling in front of a purple background

Iron deficiency and women

IDA impacts nearly a third of women over the course of their lives.

  • Smaller iron stores: On average, women only have enough available iron stored in their body for about six months, while men have enough for about three years.
  • Blood loss: About 1 in 5 women experience excessive blood loss from menstruation, a leading cause for IDA.
  • Long-term impact: In a study consisting mostly of women, 58% of people diagnosed with ID still had low iron levels three years later.

ID/IDA risk factors across women's lives

  1. Pre-Reproductive Years

    Growth Spurts 
    Nearly 40% of females ages 12-21 are affected by ID in the United States. 

  2. Reproductive Years

    Menorrhagia 
    About 20% women experience excessive blood loss from periods.

    Pregnancy 
    Up to 75% of pregnant women worldwide may have iron deficiency anemia in their lifetime.

     

  3. Perimenopause

    Uterine Fibroids 
    Over 70% of women are affected by uterine fibroids in their lifetime, leading to chronic blood loss.

  4. Postmenopause

    Poor Iron Absorption
    One of the most common causes of IDA in postmenopausal women is malabsorption.

Other common risk factors not limited to a specific life stage:

  • Starting menstruation
  • Plant-based diets
  • High intensity sports
  • Heavy exercise
  • Chronic inflammation

ACCRUFeR's impact

ACCRUFeR works differently than traditional iron treatments because it's designed differently. In clinical studies, ACCRUFeR’s patented MALTOL SHIELD™ delivered the following benefits for adults with ID/IDA:

MALTOL SHIELD(TM) closed: Protects iron from oxidizing in the stomach MALTOL SHIELD (TM) opened: Releases iron only when ready for absorption in the small intestine Unused ACCRUFeR excreted: Stays protected, helping patients avoid free iron and irritation

Fewer than 5% of patients taking ACCRUFeR stopped taking it because of adverse reactions.*
*Out of 175 patients

ACCRUFeR increased hemoglobin levels as early as week 4 and patients maintained improvements in hemoglobin at 64 weeks.

ACCRUFeR’s MALTOL SHIELDTM keeps iron protected from the stomach for optimal iron absorption where it's needed in the small intestine.

A low, 30mg dose of ACCRUFeR twice per day did not lead to iron overload.

Woman lying on the couch with exhaustion below The Every Mom logo

Foggy and exhausted during motherhood?

For many women, persistent exhaustion and brain fog may actually be linked to iron deficiency. Check out ACCRUFeR's spotlight in "The Everymom" to learn more about how iron deficiency can show up, when it may be worth paying closer attention, and treatment options.

Read the article